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Abstract – Bartonella rochalimae was ﬁrst isolated from the blood of a human who traveled to Peru
and was exposed to multiple insect bites. Foxes and dogs are likely natural reservoirs for this
bacterium. We report the results of experimental inoculation of two dogs, ﬁve cats and six guinea
pigs with the only human isolate of this new Bartonella species. Both dogs became bacteremic for 5–7
weeks, with a peak of 10
3–10
4 colony forming units (CFU)/mL blood. Three cats had low bacteremia
levels (< 200 CFU/mL) of 6–8 weeks’ duration. One cat that remained seronegative had two
bacterial colonies isolated at a single culture time point. A ﬁfth cat never became bacteremic, but
seroconverted. None of the guinea pigs became bacteremic, but ﬁve seroconverted. These results
suggest that dogs could be a reservoir of this strain of B. rochalimae, in contrast to cats and guinea
pigs.
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1. INTRODUCTION
Bartonella infection was ﬁrst identiﬁed in
dogs in 1993, when a novel Bartonella subspe-
cies,B.vinsoniisubsp.berkhofﬁi(B.v.berkhofﬁi),
was isolated from a dog with vegetative
valvular endocarditis [3]. In the subsequent
ten years after recognition of this organism in
domestic dogs, six other species of Bartonella
were identiﬁed in dogs, in association with var-
ious clinical manifestations [6]. To date, only
two studies have been published on experimen-
tal infection of dogs with Bartonella,b o t ho f
which investigated the immunological response
and natural history of infection with B. v. berkh-
ofﬁi in dogs [18, 19]. Blood culture and poly-
merase chain reaction (PCR) of DNA
extracted from blood or tissue suggested the
establishment of chronic infection despite sub-
stantial production of B. v. berkhofﬁi-speciﬁc
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Article published by EDP Sciencesantibodies in both studies. In one of these stud-
ies, all six B. v. berkhofﬁi inoculated dogs sero-
converted by day 7 post inoculation (PI) using
an indirect immunoﬂuorescence antibody
(IFA) assay, and all had elevated antibody titers
( 1:64) for more than 100 days PI [19].
Bartonella rochalimae was ﬁrst isolated
from the blood of a human patient who pre-
sented with fever, rash, and splenomegaly after
traveling to Peru where she received multiple
insect bites [9]. Previously described as Barton-
ella clarridgeiae-like, this zoonotic Bartonella
species has also been isolated from domestic
dogs, gray foxes, raccoons and coyotes in Cal-
ifornia [11, 12]. Sequential infection with
B. v. berkhofﬁi followed by B. rochalimae has
been observed in a naturally infected gray
fox, suggesting a lack of cross-protection
between these Bartonella species [11].
B. rochalimae DNA (originally described as a
B. clarridgeiae-like species) was also detected
in one dog with endocarditis [12, 17]. Because
exposure to B. rochalimae likely occurred when
the American woman tourist was traveling in
Peru, we sought to identify which of the domes-
tic animals usually present in traditional rural
Peruvian households, i.e. dogs, cats and guinea
pigs, could serve as a permissive reservoir host
for B. rochalimae, using experimental inocula-
tion of animals with the only human isolate
available worldwide [9]. Even though the
American tourist denied exposure to cats during
her trip to Peru [9], and pet cats are not as com-
mon as dogs in traditional rural Peruvian house-
holds, it was nevertheless important to
investigate the susceptibility of cats to this
human strain, because B. rochalimae is most
closely related genetically to B. clarridgeiae,a
species for which cats are the natural reservoir
[6]. Finally, because guinea pigs (Cavia
porcellus) are commonly raised indoors, roam-
ing free in Peruvian rural households [7, 8], we
inoculated guinea pigs to investigate their role
as a potential reservoir of B. rochalimae. Fur-
thermore, guinea pigs are commonly infested
by Pulex simulans ﬂeas that will feed readily
on humans, and a Bartonella species nearly
identical to the human isolate of B. rochalimae
[9] was identiﬁed in a Pulex ﬂea collected on a
human in Cuzco, Peru, based on the sequence
of a fragment of the intergenic spacer region
(ITS) [20]. Since then, B. clarridgeiae-like/
B. rochalimae DNA has also been detected in
rodent ﬂeas from Egypt [16], China [14]a n d
the USA [1], and has been isolated from ﬁeld
mice from Slovenia [13]a n dab r o w nr a t( Rat-
tus norvegicus) from Taiwan [15], suggesting a
role for rodents as reservoirs of B. rochalimae.
We hypothesized that dogs are more likely to
express higher bacteremia levels over a longer
period of time than cats when inoculated with
the human strain, based on previous experimen-
tal infections using a strain isolated from a wild
carnivore. Because rodents could harbor
B. rochalimae or B. rochalimae-like bacteria,
we hypothesized that guinea-pigs are a potential
reservoir for B. rochalimae.
Our objectives were to evaluate the suscepti-
bility of cats and guinea-pigs to the unique
human isolate of B. rochalimae and conﬁrm
that dogs, which have been shown to be natu-
rally infected with B. rochalimae [11], represent
a permissive host for infection with this human
isolate. We also sought to conﬁrm a lack of
cross-protection between B. v. berkhofﬁi and
B. rochalimae, as observed in natural infections
in wild carnivores. We studied experimental
infection with the only human B. rochalimae
strain in two dogs (one dog had been inoculated
previously with B. v. berkhofﬁi and the other
dog had no prior exposure to Bartonella), ﬁve
cats, and six guinea pigs. We determined dura-
tion of B. rochalimae bacteremia, antibody
kinetics, and serological cross-reactivity with
other Bartonella antigens for this study; these
parameters have not been examined previously
for B. rochalimae infection in domestic dogs
and cats.
2. MATERIALS AND METHODS
2.1. Animals
Two mongrel male dogs (approximately 3 and 6
years old) that were seronegative and culture negative
for Bartonella were obtained through the Center for
Laboratory Animal Science, University of California,
Davis, USA (UCD) for the study. Five 13-month-old
neutered male cats that were seronegative and culture
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Feline Research Colony at UCD for the study. Six
adult guinea pigs (three males and three females)
shown to be blood culture negative and seronegative
for Bartonella spp. were obtained from the Animal
Science Department, UCD. All animals were raised
in a ﬂea and tick free environment, the dogs and gui-
n e ap i g sh a v i n gb e e nu s e di no t h e re x p e r i m e n t sp r i o r
to this study. None of these animals had been previ-
ously used in experimental infections with animal or
human pathogens. The dogs, cats and guinea pigs
were maintained in accordance with guidelines of
the Institutional Animal Care and Use Committee
(IACUC) and were examined by a veterinarian at
least once to twice a week throughout the study
period.
2.2. Experimental design and bacterial culture
For the two dogs, B. v. berkhofﬁi (ATCC # 51672)
or B. rochalimae (Human strain: ATCC #BAA-1498)
were plated onto 5% rabbit blood agar and incubated
at 35  C for 4–5 days. The harvested colonies were
suspended into sterile saline and a total of 0.5 mL
was inoculated intradermally in 3 to 5 sites near the
shoulder blade, as previously described [2]. Prior to
inoculation with B. rochalimae, Dog 1 was inocu-
lated with 2.4 · 10
9 colony forming units (CFU)/
mL of B. v. berkhofﬁi and blood samples collected
twice a week during the ﬁrst 4 weeks and then
weekly for the two following months. After inocula-
tion with B. rochalimae, dogs were bled at least twice
a week for the ﬁrst 5 weeks following inoculation
and then once weekly thereafter. All blood samples
(500 lL to 1 mL of blood per animal) were cultured
on heart infusion agar containing 5% rabbit blood
and incubated in 5% CO2 at 35  C for up to 4 weeks
[4, 5]. After Dog 1 had been culture-negative for
B. v. berkhofﬁi for one month, both Dog 1 and Dog
2 were inoculated with 3.5 · 10
8 CFU/mL of
B. rochalimae. The two dogs were then followed
using blood culture and IFA for three months.
Isolates from both dogs were conﬁrmed to be
B. rochalimae (and not B. v. berkhofﬁi) by PCR-
RFLP [12] for the ﬁrst positive blood culture after
inoculation with B. rochalimae, and randomly there-
after for Dog 1.
The cats were inoculated with a total of 0.5 mL
by the intradermal route in 3 to 4 different sites
behind the shoulder blade of a 1.7 · 10
8 CFU/mL
suspension of B. rochalimae (Human strain: ATCC
#BAA-1498) and clinically monitored daily for the
ﬁrst week. Cats were bled once a week for 15 weeks.
Blood culture and serology testing were performed as
previously described [23], and the ﬁrst positive
blood culture conﬁrmed to be B. rochalimae by
PCR-RFLP.
The six guinea pigs were experimentally inocu-
lated with a total of 0.4 to 0.5 mL by intradermal
route (in 3 to 4 different sites on the back) with a
6.1 · 10
8 CFU/mL suspension of B. rochalimae
a n dm o n i t o r e dd a i l yf o rt h eﬁ r s tw e e k .Ab l o o ds a m -
ple (0.1 to 0.2 mL) was collected aseptically by intra-
venous puncture (saphenous vein) every week for 8
weeks. Blood culture and serology testing were per-
formed as previously described [23]. Because of the
low volume of whole blood collected, only
25 to 100 lLo fw h o l eb l o o df r o me a c hg u i n e ap i g
was plated onto 5% rabbit blood agar.
2.3. Serology
For serological testing of the two dogs, only
samples collected at weekly intervals were tested
by IFA for antibodies against B. v. berkhofﬁi,
B. clarridgeiae, B. rochalimae,a n dB. henselae,t o
examine antibody response and cross-reactivity. All
IFA slides were prepared the same way by infecting
Vero cells with the various strains, as previously
described [11]. Cats and guinea pigs were
only tested for presence of antibodies against
B. rochalimae by IFA and a titer  1:64 was con-
sidered positive. For the guinea-pig samples, we
used a goat anti-guinea pig conjugate at 1:100
dilution (Kirkegaard and Perry Laboratories (KPL),
Gaithersburg, MD 20879, USA).
3. RESULTS
No physical or clinical abnormalities, except
for a small focus of inﬂammation (redness,
swelling) at the inoculation site, were observed
in the dogs during the study. None of the cats or
guinea pigs presented any abnormal clinical
signs during the course of the study.
After inoculation with B. v. berkhofﬁi,D o g1
developed a positive blood culture by day 17 PI
and remained culture positive through day 59
PI. The mean level of bacteremia over these
43 days was 2 · 10
2 CFU/mL. Initial recipro-
cal IFA titers against B. v. berkhofﬁi were
< 1:16, rose to 1:64 by day 9 PI and peaked
at 1:256 within 2 weeks of the ﬁrst positive
blood culture (Fig. 1). The B. v. berkhofﬁi
antibody titer was < 1:16 at the time of
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the ﬁrst inoculation with B. v. berkhofﬁi.T h e r e
was no cross reactivity of anti-B. v. berkhofﬁi
antibodies with antigens from other Bartonella
species by IFA, and titers for B. clarridgeiae,
B. rochalimae,a n dB. henselae remained
 1:16 (Fig. 1). Following inoculation with
B. rochalimae, Dog 1 became blood culture
positive for B. rochalimae (speciation con-
ﬁrmed by PCR-RFLP) at day 24 PI (118 days
after inoculation with B. v. berkhofﬁi)a n d
remained bacteremic through day 62 PI
(Tab. I). A substantial increase in Bartonella
IFA antibody titers was not observed until 18
days (day 42 PI) after B. rochalimae bacteremia
was ﬁrst observed. B. rochalimae and
B. v. berkhofﬁi titers both peaked at 1:1024 on
day 163 PI and demonstrated substantial cross
reactivity with the other Bartonella antigens
tested (Fig. 1). Dog 2, inoculated only with B.
rochalimae, had a positive blood culture by
day 10 PI and remained culture positive
through day 80 PI. Bacteremia peaked at day
17 PI (5.5 · 10
4 CFU/mL) and decreased
through day 42 PI. There was one negative cul-
ture on day 49 PI, followed by a second and
lower increase in bacteremia with a peak of
5.1 · 10
2 CFU/mL on day 69 PI. Detectable
levels of bacteremia ranged from 8 CFU/mL
to 5.1 · 10
3 CFU/mL in Dog 1 and from
1C F U / m L t o 5 . 5· 10
4 CFU/mL in Dog 2.
Mean level of bacteremia was 7.6 · 10
2 CFU/
m Lf o rD o g1a n d8· 10
3 CFU/mL for Dog 2.
B. rochalimae IFA antibody titers (> 1:16) were
not observed in Dog 2 until day 24 PI, 14 days
after Bartonella infection was detected by blood
cultureandtitersincreasedrapidlyandpeakedat
1:1024 on day 32 PI. Moderate to low seroreac-
tivity toB.clarridgeiaeandB.henselaeantigens
was also observed in this dog, whereas
B. v. berkhofﬁi antibody titers remained  1:32
(Fig. 2).
Bacteremia was detected in 4 of the 5 cats.
In three cats, bacteremia was detected at week
3 PI, peaked between weeks 6 and 7, and
resolved by weeks 8 to 10. A fourth cat had a
transient and low level bacteremia (2 CFU/
mL) on week 12, and the ﬁfth cat remained cul-
ture negative throughout the 15-week study per-
iod. Overall, the level of bacteremia was low
(less than 10 CFU/mL for one cat, less than
50 CFU/mL for two cats, and less than
200 CFU/mL for one cat) and at least 10–100
times less than in the two dogs. Four of the ﬁve
cats seroconverted (Tab. II). Three cats were
seropositive for B. rochalimae 3 weeks PI, with
titers ranging from1:64 to 1:512 untilthe end of
the study (week 15), and one cat seroconverted
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Figure 1. IgG antibody response in Dog 1 experimentally infected with B. v. berkhofﬁi and challenged with
B. rochalimae. The dog was tested by IFA for antibodies against B. v. berkhofﬁi (Bvb), B. rochalimae (Br),
B. clarridgeiae (Bc), and B. henselae (Bh). The dog was inoculated with a strain of B. rochalimae on
B. v. berkhofﬁi PI day 94 (day 0 in parentheses on X axis).
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Interestingly,theonlyseronegativecathadavery
low bacteremia (2 CFU/mL) at one point time
(week 12 PI).
None of the six guinea pigs became bactere-
mic during the 8 weeks they were tested
(Tab. I). All animals were seronegative on day
5PI(Tab. II),threebegantoshowB.rochalimae
Table I. Weekly total number of colony forming units (CFU) per mL of blood for dogs, cats and guinea pigs
experimentally inoculated with B. rochalimae.
Week Bacteremia (CFU/mL)
Dogs Cats Guinea pigs
(N =6 ) D1
* D2 C1 C2 C3 C4 C5
0 0 0 00000 0
1 0 0 00000 0
2 0 392 0 0 0 0 0 0
3 0 5.5 · 10
4 10022 0
4 72 3.3 · 10
4 3001 02 0
55 · 10
3 1.2 · 10
3 5006 40 0
6 4 7 2 0 600 1 9 1 6 0
7 18 0 18 0 0 107 12 0
8 5 7 1 40034 6 0
9 8 1 1 10001 6 N D
10 0 512 0 0 0 0 1 ND
1 1 0 1 6 00000 N D
12 0 0 0 2 0 0 0 ND
13 0 0 0 0 0 0 0 ND
14 0 0 0 0 0 0 0 ND
15 0 0 0 0 0 0 0 ND
* Previously inoculated with B. v. berkhofﬁi.
ND = Not done.
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Figure 2. IgG antibody response in Dog 2 experimentally infected with B. rochalimae. This dog was tested
by IFA for antibodies against B. v. berkhofﬁi (Bvb), B. rochalimae (Br), B. clarridgeiae (Bc), and
B. henselae (Bh).
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Four of the 6 animals were seropositive by day
32 PI (range 1:64 to 1:128). At the end of the
study (day 53 PI), all but one guinea pig had
seroconverted (titer range: 1:64 to 1:256).
4. DISCUSSION
The present study, although limited in size,
demonstrates a difference in susceptibility
among domestic dogs, cats, and guinea pigs
to experimental infection with a human isolate
of B. rochalimae. To date, isolates of this new
Bartonella species have been cultured from
mammals in the new world, including from a
human who traveled to South America [9],
and from gray foxes, raccoons, coyotes and
domestic dogs in California [11, 12]. In addi-
tion, B. rochalimae has been cultured from a
red fox (Vulpes vulpes) from France
1 and a
strain closely related to B. rochalimae was
recently isolated from a rat in Taiwan [15].
In our study, inoculation of two dogs with
the human B. rochalimae isolate led to a suc-
cessful infection, with bacteremia lasting
5 to 7 weeks and a peak bacteremia reaching
10
3 to 10
4 CFU/mL. This level of bacteremia is
similar to the level observed in two dogs experi-
mentally infected with a B. rochalimae strain
isolated from a Californian coyote
2, and dogs
experimentally inoculated with B. v. berkhofﬁi,
another Bartonella sp. that has been isolated
from canids [18, 19]. In our investigation,
prior infection with B. v. berkhofﬁi in one dog
was not protective against infection with
B. rochalimae, which is consistent with obser-
vations in a naturally infected gray fox from
California [11], and suggests that co-infection
with these two Bartonella species could occur
in domestic dogs. Similarly, in experimentally
infected cats, a lack of cross-protection has been
demonstrated between B. henselae and
B. clarridgeiae [22]. Following inoculation
with B. v. berkhofﬁi, Dog 1 developed only
moderately elevated (1:256) IFA titers against
B. v. berkhofﬁi but not against the other antigens
Table II. B. rochalimae antibody titers in experimentally infected cats and guinea pigs.
Week IFA antibody titers
Cats Guinea-pigs
C1 C2 C3 C4 C5 GP1 GP2 GP3 GP4 GP5 GP6
0 0 0 0 0 0000000
1 0 0 0 0 0000000
2 0 06 4 0 0 N DN DN DN DN DN D
3 0 0 64 64 64 64 0 0 0 64 64
4 0 0 64 64 64 128 64 64 0 128 64
5 0 0 64 128 64 ND ND ND ND ND ND
6 0 0 64 256 64 ND ND ND ND ND ND
7 0 0 64 256 64 ND ND ND ND ND ND
8 0 0 64 256 64 128 128 128 0 128 64
9 64 0 64 512 128 ND ND ND ND ND ND
10 64 0 64 256 128 ND ND ND ND ND ND
11 64 0 64 512 128 ND ND ND ND ND ND
12 64 0 64 256 256 ND ND ND ND ND ND
13 64 0 64 256 128 ND ND ND ND ND ND
14 64 0 64 256 256 ND ND ND ND ND ND
15 64 0 64 512 64 ND ND ND ND ND ND
ND = Not done.
1 Henn et al., unpublished data.
2 Chomel et al., unpublished data.
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within 35 days of the last positive blood
culture. In contrast, dogs experimentally inocu-
lated with B. v. berkhofﬁi in another study had
B. v. berkhofﬁi antibody titers that remained
elevated ( 1:64) for more than 100 days PI
[19]. The low and rapid decline in antibody
titers in Dog 1 could be a result of the failure
of B. v. berkhofﬁi to establish persistent infec-
tion. In both dogs, a detectable B. rochalimae
IgG antibody response appeared 2–3 weeks fol-
lowing the appearance of the ﬁrst positive blood
culture. Dog 1, previously exposed to
B. v. berkhofﬁi, had IFA titers of  512 against
all four Bartonella antigens, whereas for Dog 2
high IFA titers were only observed for
B. rochalimae antigens. Previous studies have
noted a correlation between high IFA titers
and seroreactivity to multiple Bartonella spe-
cies [10, 21]. These limited results suggest that
infection or re-infection with multiple species of
Bartonella could substantially increase the
serological cross reactivity between Bartonella
species. As co-infection with more than one
Bartonella species has been documented in
several animal species, including dogs and
humans, examination of cross-reactivity in nat-
urally-exposed animals becomes more chal-
lenging and would require immuno-absorption
studies.
In contrast to observations in experimentally
infected dogs, the experimentally infected cats
did not show high levels of bacteremia. The
peak bacteremia was above 100 CFU/mL in
only one of the ﬁve cats, and was at least
10 to 100 fold lower than in experimentally
infected dogs. Levels of bacteremia were also
much lower than in cats experimentally infected
with B. henselae or B. clarridgeiae [22–24].
Based on this small study, cats do not appear
to be highly susceptible to the human isolate
of B. rochalimae and are unlikely to constitute
a natural reservoir for this human strain. There
are no reports in the published literature of cats
infected with B. rochalimae and other
B. clarridgeiae-like spp. On the other hand,
despite recent reports of the presence of
B. clarridgeiae-like/B. rochalimae strains in
rodents and rodent ﬂeas, we were unable to
detect infection with B. rochalimae in the six
experimentally inoculated guinea pigs, despite
a high inoculum dose (10
8 CFU/mL). The lack
of detection could be related to the low volume
of blood cultured and/or to a very low level of
bacteremia. As the guinea-pigs were bled only
once a week, detection of a very short term bac-
teremia could have been missed. Although we
did not detect B. rochalimae bacteremia, the
guinea pigs did develop a detectable humoral
immune response to the experimental
infection. Based on our data, guinea pigs do
not appear to constitute a permissive reservoir
for B. rochalimae.H o w e v e r ,ﬁ e l ds t u d i e s
should be conducted to conﬁrm our results.
In conclusion, we sought to identify poten-
tial reservoir species from which the human
strain of B. rochalimae could be acquired. We
focused on animal species commonly found in
the domestic environment to which the traveler
could have been exposed in Peru: dogs and gui-
nea pigs. We also included cats, because they
are the natural reservoir of B. clarridgeiae,t h e
Bartonella species that is closest phylogeneti-
cally to B. rochalimae. The dog appears to be
the most permissive host of cats, dogs and gui-
nea pigs, which is consistent with the isolation
of B. rochalimae strains from wildlife canids.
Further elucidation of reservoir hosts, including
other rodent species, such as rats, as well as
arthropod vectors, especially Pulex spp. ﬂeas,
for this new Bartonella species will be impor-
tant in preventing infection of humans, and
domestic and peri-domestic animals.
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